Filing Flows › Agilent Technologies (A) › Life Sciences and Diagnostics Markets revenue
Agilent Technologies (A) Life Sciences and Diagnostics Markets revenue by quarter
Agilent Technologies' Life Sciences and Diagnostics Markets revenue was $746M in Q3 FY26 (third quarter fiscal 2026), +2% from Q2 FY26. Over the last 6 quarters it ranged from $654M (Q2 FY25) to $755M (Q4 FY25).
| Quarter | Life Sciences and Diagnostics Markets revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $746M | +2% | +11% |
| Q2 FY26 | $732M | +8% | +12% |
| Q1 FY26 | $679M | -10% | — |
| Q4 FY25 | $755M | +13% | — |
| Q3 FY25 | $670M | +2% | — |
| Q2 FY25 | $654M | — | — |
Q3 FY26 at a glance
Agilent Technologies, Q3 FY26: revenue $1.9B (+8% year over year), operating margin 23.6%, net earnings $362M, operating cash flow $519M. The chart follows the revenue to costs, profit and cash.
Questions
What is Agilent Technologies' Life Sciences and Diagnostics Markets revenue?
Agilent Technologies' Life Sciences and Diagnostics Markets revenue was $746M in Q3 FY26 (third quarter fiscal 2026), +2% from Q2 FY26.
How has Agilent Technologies' Life Sciences and Diagnostics Markets revenue changed?
Over the last 6 quarters it ranged from $654M (Q2 FY25) to $755M (Q4 FY25).